BCRX Jul 2024 4.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

2.4000

0.0000

(0.00%)

As of 11:22AM EDT. Market open.

Loading interactive chart...

Simply Wall St.
BioCryst Pharmaceuticals Insiders Added US$1.05m Of Stock To Their Holdings
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Simply Wall St.
Most Shareholders Will Probably Agree With BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) CEO Compensation
Key Insights BioCryst Pharmaceuticals' Annual General Meeting to take place on 12th of June Salary of US$665.6k is part...
GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted 10 newly-hired employees stock options to purchase an aggregate of 74,875 shares, and restricted stock units (RSUs) covering an aggregate of 39,050 shares, of BioCryst common stock. The options and RSUs were granted as of May 31, 2024, as inducements material to each employee entering into employment